Introduction
The platform is a new micro-sample primary culture and drug efficacy detection technology. Based on primary cultured tumor cells in two-dimensional and three-dimensional culture systems, tumor micro-organ structures can be formed in three-dimensional systems to build in vitro simulated tumor models. , to complete the sensitivity evaluation of antitumor drugs. The platform aims to build a tumor surrogate that is as perfect as possible, replicate the tumor in the patient's body to the outside of the body, establish multiple parallel samples, test the efficacy of various treatment methods, and guide clinical precision medicine.
advantage
1. The technology has been verified by multiple tumor samples, and the in vitro efficacy evaluation is highly consistent with clinical practice.
2. It can break through the limitations of treatment methods, including the prediction of the efficacy of targeted drugs, the prediction of the sensitivity of chemotherapeutic drugs, and the prediction and evaluation of the efficacy of radiotherapy, immunotherapy, and combination therapy.
